Learning Objectives:
1. Describe classes and mechanism of action of immune check-point inhibitors.
2. Review most common immune-related adverse events (IrAEs).
3. Review current research on autoantibody positivity and IrAEs.
Session date:
06/15/2021 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Marco Lopez-Velazquez, M.D.